PREMIERE registry: long-term safety registry of multiple sclerosis patients from cladribine clinical trials

PREMIERE registry: Prospective observational long-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trials. Purpose is to produce long-term safety data on oral cladribine in multiple sclerosis (MS).

premiere, cladribine, safety, registry, EMR700568-012, 700568012, EMD, Merck, Serono, MS, Multiple, Sclerosis


Last Update: MEZ/CET 17.09.2017, 01:19:43 Uhr | BACK TO HOMEPAGE